BRUKER CORP Debt Disclosure
20. Debt
The Company’s debt obligations consist of the following (in millions):
|
|
2025 |
|
|
2024 |
|
||
2024 term loan agreements: |
|
|
|
|
|
|
||
CHF 150 million loan due March 2027, 1.50% |
|
$ |
— |
|
|
$ |
162.1 |
|
CHF 150 million loan due March 2029, 1.50% |
|
|
180.8 |
|
|
|
162.1 |
|
CHF150 million loan due March 2031, 1.75% |
|
|
189.0 |
|
|
|
165.2 |
|
2019 term loan agreement: |
|
|
|
|
|
|
||
USD loan quarterly payments of $3.8 million and balloon payment due December 2026 |
|
|
— |
|
|
|
263.3 |
|
Note Purchase Agreements (NPA – Senior notes): |
|
|
|
|
|
|
||
CHF 50 million due April 15, 2034, 2.56% (a) |
|
|
63.0 |
|
|
|
55.1 |
|
CHF 146 million due April 15, 2036, 2.62%, and CHF 50 million due April 15, 2036, 2.60% (a) |
|
|
247.0 |
|
|
|
215.9 |
|
CHF 135 million due April 15, 2039, 2.71%, and CHF 50 million due April 15, 2039, 2.62% (a) |
|
|
233.1 |
|
|
|
203.8 |
|
CHF 300 million due December 8, 2031, 0.88% (a) |
|
|
378.1 |
|
|
|
330.5 |
|
CHF 297 million due December 11, 2029, 1.01% (a) |
|
|
374.3 |
|
|
|
327.2 |
|
EUR 150 million due December 8, 2031, 1.03% (a) |
|
|
176.0 |
|
|
|
155.3 |
|
CHF revolving loan (in U.S. Dollars) under the 2024 Revolving Credit Agreement |
|
|
— |
|
|
|
27.5 |
|
Other loans |
|
|
11.2 |
|
|
|
11.9 |
|
Unamortized debt issuance costs |
|
|
(2.4 |
) |
|
|
(3.1 |
) |
Total notes and loans outstanding (b) |
|
$ |
1,850.1 |
|
|
$ |
2,076.8 |
|
Finance lease obligations |
|
|
19.0 |
|
|
|
17.5 |
|
Total debt |
|
$ |
1,869.1 |
|
|
$ |
2,094.3 |
|
Current portion of long-term debt and finance lease obligations |
|
|
(16.6 |
) |
|
|
(32.5 |
) |
Total long-term debt, less current portion |
|
$ |
1,852.5 |
|
|
$ |
2,061.8 |
|
Significant borrowings and repayments
The following table summarizes the Company’s debt borrowings and repayments from long-term debt for the years ended December 31 (in millions):
|
|
|
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Proceeds from revolving lines of credit: |
|
|
|
|
|
|
|
|
|
|||
2024 Amended and Restated Credit Agreement |
|
$ |
750.5 |
|
|
$ |
981.4 |
|
|
$ |
— |
|
2019 Amended and Restated Credit Agreement (a) |
|
|
— |
|
|
|
268.9 |
|
|
|
— |
|
Proceeds from revolving lines of credit - Total |
|
$ |
750.5 |
|
|
$ |
1,250.3 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|||
Repayments of revolving lines of credit: |
|
|
|
|
|
|
|
|
|
|||
2024 Amended and Restated Credit Agreement |
|
$ |
(778.8 |
) |
|
$ |
(1,212.7 |
) |
|
$ |
— |
|
Repayments of revolving lines of credit - Total |
|
$ |
(778.8 |
) |
|
$ |
(1,212.7 |
) |
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|||
Proceeds from long-term debt: |
|
|
|
|
|
|
|
|
|
|||
CHF notes under various 2024 Note Purchase Agreements |
|
$ |
— |
|
|
$ |
472.1 |
|
|
$ |
— |
|
CHF notes under the 2024 Term Loan Agreement |
|
|
— |
|
|
|
495.6 |
|
|
|
— |
|
Other |
|
|
3.5 |
|
|
|
6.0 |
|
|
|
2.0 |
|
Proceeds from long-term debt - Total |
|
$ |
3.5 |
|
|
$ |
973.7 |
|
|
$ |
2.0 |
|
|
|
|
|
|
|
|
|
|
|
|||
Repayment of long-term debt: |
|
|
|
|
|
|
|
|
|
|||
USD notes under the 2012 Note Purchase Agreement |
|
$ |
— |
|
|
$ |
(100.0 |
) |
|
$ |
— |
|
USD notes under the 2019 Term Loan Agreement |
|
|
(263.3 |
) |
|
|
(15.0 |
) |
|
|
(15.0 |
) |
CHF notes under the 2024 Term Loan Agreement |
|
|
(189.4 |
) |
|
|
(6.4 |
) |
|
|
— |
|
Other |
|
|
(13.8 |
) |
|
|
(14.0 |
) |
|
|
(8.5 |
) |
Repayment of long-term debt - Total |
|
$ |
(466.5 |
) |
|
$ |
(135.4 |
) |
|
$ |
(23.5 |
) |
Covenants
As of December 31, 2025, the Company was in compliance with all financial covenants of all debt agreements. The Company’s debt agreements’ covenants consist of customary affirmative and negative covenants, including, among others, restrictions on the Company’s ability to incur liens, transfer or sell equity or assets, engage in certain mergers and consolidations, enter into transactions with affiliates, and engage or permit any subsidiary to engage in certain lines of business. They also include customary representations and warranties and events of default. The events of default include, among others, payment defaults, defaults in the performance of affirmative and negative covenants, the inaccuracy of representations and warranties, bankruptcy and insolvency related events, certain ERISA events, material judgments, and the occurrence of a change of control.
Hedging
As of December 31, 2025, the Company has several cross-currency swap agreements with a notional value of $124.1 million of U.S. Dollar to Swiss Franc and a notional value of $124.1 million of U.S. Dollar to Euro to hedge the variability in the movement of foreign currency exchange rates on portions of our Euro and Swiss Franc denominated net asset investments. Refer to Note 22, Derivative Instruments and Hedging Activities for more information.
Revolving Credit Facility
As of December 31, 2025, the maximum commitments and net amounts available under (i) the 2024 Revolving Credit Agreement and (ii) other lines of credit with various financial institutions located primarily in Germany and Switzerland that are unsecured and typically due upon demand are as follows (dollars in millions):
|
|
Weighted |
|
Total Amount |
|
|
Outstanding |
|
|
Outstanding |
|
|
Total |
|
||||
2024 Amended and Restated Credit |
|
0.20% |
|
$ |
900.0 |
|
|
$ |
— |
|
|
$ |
0.7 |
|
|
$ |
899.3 |
|
Bank guarantees and working capital line |
|
varies |
|
|
211.2 |
|
|
|
— |
|
|
|
211.2 |
|
|
|
— |
|
Total revolving lines of credit |
|
|
|
$ |
1,111.2 |
|
|
$ |
— |
|
|
$ |
211.9 |
|
|
$ |
899.3 |
|
Key terms
An overview of the key terms of each of the term loan agreements, note purchase agreements and revolving credit agreements are described below.
2024 Term Loan Agreements
On March 29, 2024, the Company, as borrower, entered into (i) a term loan agreement (the “Three- and Five-Year Term Loan Agreement”) and (ii) another term loan agreement (the “Seven-Year Term Loan Agreement” and together with the Three- and Five-Year Term Loan Agreement, the “Term Loan Agreements”) with a group of bank lenders.
Each term loan facility has a delayed draw component allowing for up to two borrowings under the relevant loan facility during the period from and including the effective date to the earlier of (i) September 30, 2024 and (ii) the date of termination of the commitments by the Administrative Agent during the continuance of an Event of Default as defined in the applicable Term Loan Agreement.
Amounts outstanding under the 2024 Term Loan Agreements bear interest at a rate equal to (a) the Swiss Average Rate Overnight (SARON), plus a margin ranging from (i) 1.000% to 1.500% in the case of the three- and five-year term loan facilities and (ii) 1.250% to 1.750% in the case of the seven-year term loan facilities, in each case, based on the Company’s leverage ratio, provided, however, that if the loans are required to bear interest determined by reference to an Alternate Base Rate (“ABR Loans”), then such ABR Loans shall bear interest equal to (i) the federal funds effective rate plus ½ of 1%, (ii) the prime rate announced by Bank of America, N.A., and (iii) 1%, plus a margin ranging from 0.100% to 0.200%, based on the Company’s leverage ratio.
Loans under the 2024 Term Loan Agreements will be repayable in full at maturity, subject to scheduled quarterly amortization payments on (i) the three-year and five-year term loan facilities beginning in June 2024 and (ii) the seven-year term loan facility beginning in June 2026, and, in each case, may also be prepaid at the Company’s option in whole or in part without premium or penalty. In addition, obligations are unsecured and are fully and unconditionally guaranteed by certain of the Company’s subsidiaries.
The other terms of the 2024 Term Loan Agreements are substantially similar to the terms of the 2024 Revolving Credit Agreement, including representations and warranties, affirmative, negative and financial covenants, events of default, and leverage and the interest coverage ratio.
Notes Purchase Agreements (“NPAs” or “Notes”)
The Company has entered into several NPAs with groups of accredited institutional investors including on February 1, 2024, and February 8, 2024 (“2024 Note Purchase Agreements”), December 7, 2021 (“2021 Note Purchase Agreement”) and on December 11, 2019 (“2019 Note Purchase Agreement”).
The key terms associated with these NPAs are as follows:
The other terms of the NPAs are substantially similar to the terms of the 2024 Revolving Credit Agreement, including representations and warranties, affirmative, negative and financial covenants, events of default, and interest coverage ratio. The leverage ratio for the NPAs was not affected by the RCA amendment, noted below.
2024 Amended and Restated Credit Agreement
On January 18, 2024, the Company and certain subsidiaries entered into an agreement that amended and restated the 2019 Revolving Credit Agreement which was entered into on December 11, 2019. This resulted in the aggregate amount available to draw increasing to $900 million from $600 million and an extension of the maturity date to January 18, 2029, as may be further extended by the Company for the periods and on the terms set forth in the 2024 Amended and Restated Credit Agreement (“2024 RCA”).
In addition, the 2024 RCA increases the uncommitted incremental facility whereby, under certain circumstances, the Company may, at its option, increase the amount of the revolving facility or incur term loans in an aggregate amount not to exceed $400 million. Amounts outstanding under the 2024 RCA bear interest at a rate equal to, at the Company’s option, (a) the Secured Overnight Financing Rate (“SOFR”) applicable to the relevant currency, plus a margin ranging from 1.000% to 1.500%, based on the Company’s leverage ratio, or (b) the highest of (i) the federal funds effective rate plus 0.5%, (ii) the prime rate announced by Bank of America, N.A., and (iii) SOFR, as adjusted, plus 1.00%, plus a margin rate ranging from 0.000% to 0.500%, based on the Company’s leverage ratio. The Company has also agreed to pay a quarterly facility fee based on the aggregate amount available under the 2019 Revolving Credit Agreement ranging from 0.100% to 0.200%, based on the Company’s leverage ratio.
The 2024 RCA includes affirmative, negative and financial covenants and events of default customary for financings of this type. The negative covenants include, among others, restrictions on liens, indebtedness of the Company and its subsidiaries, asset sales, dividends, and transactions with affiliates not approved under the agreements. The financial covenants require the Company to maintain a maximum leverage ratio of 3.50 to 1.00 (the “Stated Leverage Ratio” or “SLR”) and a minimum interest coverage of to 1.00. In accordance with the terms of the 2024 RCA, the Company can elect to increase the maximum leverage ratio to 4.00 to 1.00, the “Adjusted Leverage Ratio” or “ALR” provided that it shall (1) step down the ALR by 0.25x after two full fiscal quarters following the date of a Material Acquisition, and (2) return to the otherwise SLR after four full fiscal quarters following the date of such Material Acquisition, provided, that the Company may not elect to increase the maximum leverage ratio to the ALR unless there shall be at least one full fiscal quarter immediately prior to such election during which the SLR is in effect. The leverage ratio calculation was amended in October 2025 to allow for the total debt to be stated in U.S. Dollars at the exchange rate date on which the debt originated.
Proceeds of the 2024 RCA may be used by the Company and its subsidiaries to finance working capital needs, refinance or reduce existing indebtedness and for general corporate purposes, including acquisitions.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 27, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Mar 1, 2023 | |
| 2021 | Feb 28, 2022 | |
| 2020 | Mar 1, 2021 | |
| 2019 | Mar 27, 2020 | |
| 2018 | Mar 1, 2019 | |
| 2017 | Mar 16, 2018 | |
| 2016 | Mar 1, 2017 | |
| 2015 | Feb 29, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.